Find verified Insulin aspart API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Insulin aspart for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Insulin aspart API.
Alternate Names: Aspart insulin, Ins novorapid, Fiasp, Novolog
CAS No: 116094-23-6
PubChem CID: 16132418
Mol Formula: C256H387N65O79S6
Mol Weight: 5832 g/mol
IUPAC Name: (4S)-4-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2 -Show More
Therapeutic use: Antidiabetic agents
Drug Class: Biologics, Hormones, Hypoglycemics, Insulin analogues, Peptides
Commercial / Development Status: Commercial APIs
Source / Manufacturing Origin: Peptide APIs
API Description: Insulin aspart is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood) in adults and children.15 Au
